Drug distributor McKesson and private equity firm Clayton Dubilier & Rice on Tuesday agreed to take infusion therapy provider Option Care Health private in a deal worth about $5.8 billion including ...
CD&R and McKesson MCK-1.14%decrease; down pointing triangle will acquire Option Care Health, which offers infusion therapy and services to patients at home, for about $5.8 billion including debt.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Healthcare group McKesson and private equity firm Clayton Dubilier & Rice are teaming up to buy the largest ...
Oct 5 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a ...
McKesson to invest about $1.4 billion for 49% stake in Option Care Deal expected to close in first half of 2027 Option Care is the largest independent US infusion therapy provider The per-share offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results